About The Study: The elimination of cost sharing might be associated with increased naloxone dispensing to commercially insured and Medicare patients.
About The Study: The elimination of cost sharing might be associated with increased naloxone dispensing to commercially insured and Medicare patients.
Corresponding Author: To contact the corresponding author, Kao-Ping Chua, M.D., Ph.D., email chuak@med.umich.edu.
To access the embargoed study: Visit our For The Media website at this link
(doi:10.1001/jama.2024.8378)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time
Journal
JAMA
